highly significantP =0.001
The TNM staging system was an independent prognostic variable: stage I showed a median survival of 60.8 months, stage II of 31.7 months and stage III of 19.3 months, with highly significant differences in survival curves ( P =0.001) after excluding the single patient with a stage IV neoplasm ( Figure 3 ).